U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Human Drug Advisory Committees
  5. Pulmonary-Allergy Drugs Advisory Committee
  6. Pulmonary-Allergy Drugs Advisory Committee Roster
  1. Pulmonary-Allergy Drugs Advisory Committee

Pulmonary-Allergy Drugs Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info

Current Number of Vacancies = 2

Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Chairperson
David H. Au, MD, MS
Expertise: Pulmonary and Critical Care Medicine
Term: 7/27/21 – 5/31/2025
Professor of Medicine
University of Washington 
Acting Executive Director
Center for Care and Payment Innovation
Office of Healthcare Innovation and Learning
Department of Veterans Affairs (VA)
VA Puget Sound Health Care System
1660 South Columbian Way
Seattle, Washington 98101

Designated Federal Officer 
Takyiah Stevenson, PharmD
Division of Advisory Committee and Consultant Management
Office of Executive Programs
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001
Fax: (301) 847-8533
E-mail: PADAC@fda.hhs.gov


Leonard B. Bacharier, MD
Expertise: Pediatric Allergy and Immunology
Term: 6/15/2022 – 5/31/2026
Professor of Pediatrics
Janie Robinson and John Moore Lee Chair in Pediatrics
Section Chief, Pediatric Allergy and Immunology
Monroe Carell Jr. Children’s Hospital
Vanderbilt University Medical Center
2200 Children's Way
11205 Doctor's Office Tower
Nashville, Tennessee 37232

*Emma H. D’Agostino, PhD
Expertise: Consumer Representative
Term: 6/15/2022 – 5/31/2026
Consultant
Cystic Fibrosis Foundation
Lead Medical Writer, BOLDSCIENCE
2400 Old Milton Parkway, Suite 245
Alpharetta, Georgia 30009


Scott E. Evans, MD, FCCP, ATSF
Expertise: Pulmonary Medicine
Term: 6/3/2019 – 5/31/2025
Professor and Chair ad interim
Department of Pulmonary Medicine
Rebecca Meyer Brown and Joseph Mellinger Brown Chair in Basic Science Research
University of Texas MD Anderson Cancer Center
1515 Holcombe Boulevard, Room FCT 12.6018
Houston, Texas 77030

Brian T. Garibaldi, MD, PhD
Expertise: Pulmonary and Critical Care Medicine
Term: 6/15/2022 – 5/31/2026
Professor of Medicine and Physiology
Division of Pulmonary and Critical Care Medicine
Johns Hopkins University School of Medicine
1830 East Monument Street, 5th Floor
Baltimore, Maryland 21287


Nicole Hamblett, PhD
Expertise: Biostatistics
Term: 9/4/2023 – 5/31/2027
Professor, Department of Pediatrics
Adjunct Professor, Department of Biostatistics
University of Washington
Co-Executive Director, Cystic Fibrosis Therapeutics Development Network Coordinating Center
Development Network Coordinating Center
Seattle Children's Research Institute
1920 Terry Avenue
Seattle, Washington 98121

Edwin H. Kim, MD, MS
Expertise: Allergy and Immunology
Term: 10/3/2019 – 5/31/2027
Associate Professor and Division Chief
Division of Pediatric Allergy and Immunology
University of North Carolina School of Medicine
116 Manning Drive, CB 8035
Chapel Hill, North Carolina 27599


**Julie Krop, MD
Expertise: Industry Representative
Term: 2/14/2024 – 10/31/2027
Chief Medical Officer and Head of Development
PureTech Health
8 Saint Ronan Terrace
New Haven, Connecticut 06511

Janet S. Lee, MD, ATSF
Expertise: Pulmonary and Critical Care Medicine
Term: 6/15/2022 – 5/31/2026
Professor of Medicine
Chief, Division of Pulmonary and Critical Care Medicine
John T. Milliken Department of Medicine
Washington University in St. Louis
660 South Euclid Avenue
St. Louis, Missouri 63110


+Renata Gontijo Lima, MD
Expertise: Industry Representative
Term: 2/14/2024 – 10/31/2027
Associate Vice President, Immunology Development
Lilly Bio-Medicines
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, Indiana 46285

Matthew A. Rank, MD
Expertise: Allergy and Immunology
Term: 9/4/2023 – 5/31/2027
Professor of Medicine
Mayo Clinic Alix School of Medicine
Chair, Division of Allergy, Asthma, and Clinical Immunology
Mayo Clinic in Arizona
13400 East Shea Boulevard
Scottsdale, Arizona 85259


*Consumer Representative
**Industry Representative (non-voting)
+Alternate Industry Representative (non-voting)
 

Updated: June 11, 2024

Back to Top